In July 2014 AbbVie Inc. and Shire Plc's announced a $54.8 billion merger deal that would have made AbbVie the largest U.S. company to move its legal residence, though not its operations, abroad in order to lower its tax rate...more
3/3/2017
/ AbbVie ,
Capital Losses ,
Inversion ,
IRS ,
Offshore Companies ,
Pharmaceutical Industry ,
Shareholder Votes ,
Stocks ,
Tax Liability ,
Tax Planning ,
Tax Rates ,
Termination Payments
Last week, the Internal Revenue Service and Treasury Department announced a number of new regulations intended to make it more difficult to qualify for tax advantages associated with inversion transactions and reduce certain...more
The increasing use of corporate inversions, whereby a company via merger achieves 20 percent or more new ownership, claims non-U.S. residence, and is then permitted to adopt that country’s lower corporate tax structure and...more